首页> 外国专利> Pharmaceutical composition for treating or preventing inflammatory diseases comprising the extract or fractions thereof of the fermented Cordyceps militaris grown on Rhynchosia nulubilis

Pharmaceutical composition for treating or preventing inflammatory diseases comprising the extract or fractions thereof of the fermented Cordyceps militaris grown on Rhynchosia nulubilis

机译:用于治疗或预防炎性疾病的药物组合物,其包含生长在Nuynbilisia nulubilis上的发酵的Cord虫草的提取物或其级分

摘要

The present invention relates to a pharmaceutical composition for preventing or treating inflammatory diseases, including an extract of fermented Cordyceps militaris cultured on Rhynchosia Nulubilis or a fraction thereof, as an active ingredient. According to the present invention, the extract of fermented Cordyceps militaris cultured on Rhynchosia Nulubilis or a fraction thereof shows no cytotoxicity, inhibits NO activity of macrophages stimulated with LPS, suppresses expression of inflammation-modulating markers iNOS and COX2, inflammatory cytokines IL-1β and TNF-α, MAPK signal transferring factors p-JNK, p-p38 and p-ERK, and inflammation-related transcription factors p-NFκB and p-IκB, reduces secretion of beta-hexosaminidase and shows an anti-allergic effect in Type I and Type IV allergy animal models, and thus can be useful for treating, preventing or alleviating inflammatory diseases.
机译:本发明涉及一种用于预防或治疗炎性疾病的药物组合物,其包括作为营养成分培养在Rh支支原体或其级分上的发酵的Cord虫草提取物。根据本发明,在努氏支原体上培养的发酵Cord虫草提取物或其部分不显示细胞毒性,抑制LPS刺激的巨噬细胞的NO活性,抑制炎症调节标记物iNOS和COX2,炎症细胞因子IL-1β和炎症因子的表达。 TNF-α,MAPK信号传递因子p-JNK,p-p38和p-ERK以及与炎症有关的转录因子p-NFκB和p-IκB减少β-己糖胺酶的分泌并在I型中显示抗过敏作用和IV型变态反应动物模型,因此可用于治疗,预防或减轻炎症性疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号